Literature DB >> 9806866

Plasmodium chabaudi chabaudi (AS): inflammatory cytokines and pathology in an erythrocytic-stage infection in mice.

C E Cross1, J Langhorne.   

Abstract

We have sought to characterize Plasmodium chabaudi chabaudi infection in mice for use as a model for malaria pathology. Different mouse strains vary in their susceptibility to the erythrocytic stages of this parasite and this is manifested not only in the outcome of infection (survival versus death) but also by differences in the numbers of circulating parasites at the peak of infection. We have shown that regardless of final outcome, both resistant and susceptible mice exhibit other parameters of disease such as loss in body weight and anemia. By contrast, other parameters such as hypothermia appear more severe in susceptible mice. The severe symptoms coincide with high levels of inflammatory cytokines in the circulation of susceptible mice, not seen in H-2-matched resistant mice. However, levels of mRNA for the same cytokines, measured in the spleen of the same mice was not significantly different between the two strains. Neutralization of IFN-gamma in vivo led to an increase in parasitemia, in both susceptible and resistant mice, but did not affect the final outcome of disease. Indeed, symptoms were exacerbated in the absence of IFN-gamma, presumably because of larger numbers of circulating parasites. These data suggest that IFN-gamma does not directly contribute to the lethal outcome of infection in susceptible strains of mice. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806866     DOI: 10.1006/expr.1998.4335

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  20 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Transforming growth factor beta-induced failure of resistance to infection with blood-stage Plasmodium chabaudi in mice.

Authors:  N Tsutsui; T Kamiyama
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Murine malaria infection induces fetal loss associated with accumulation of Plasmodium chabaudi AS-infected erythrocytes in the placenta.

Authors:  Jayakumar Poovassery; Julie M Moore
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Tumor necrosis factor alpha p55 receptor is important for development of memory responses to blood-stage malaria infection.

Authors:  C Li; J Langhorne
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Divergent roles of IRAK4-mediated innate immune responses in two experimental models of severe malaria.

Authors:  Constance A M Finney; Ziyue Lu; Michael Hawkes; Wen-Chen Yeh; W Conrad Liles; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

Review 6.  The contribution of Plasmodium chabaudi to our understanding of malaria.

Authors:  Robin Stephens; Richard L Culleton; Tracey J Lamb
Journal:  Trends Parasitol       Date:  2011-11-17

7.  Plasmodium chabaudi AS induces pregnancy loss in association with systemic pro-inflammatory immune responses in A/J and C57BL/6 mice.

Authors:  D Sarr; G M Smith; J S Poovassery; T Nagy; J M Moore
Journal:  Parasite Immunol       Date:  2012-04       Impact factor: 2.280

8.  Malaria-induced murine pregnancy failure: distinct roles for IFN-gamma and TNF.

Authors:  Jayakumar S Poovassery; Demba Sarr; Geoffrey Smith; Tamas Nagy; Julie M Moore
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

9.  Effect of Brugia pahangi co-infection with Plasmodium berghei ANKA in gerbils (Meriones unguiculatus).

Authors:  Olawale Quazim Junaid; Indra Vythilingam; Loke Tim Khaw; Sinnadurai Sivanandam; Rohela Mahmud
Journal:  Parasitol Res       Date:  2020-03-16       Impact factor: 2.289

10.  Assessment of in vivo antimalarial activities of some selected medicinal plants from Turkey.

Authors:  Ahmet Ozbilgin; Cenk Durmuskahya; Husniye Kayalar; Ipek Ostan
Journal:  Parasitol Res       Date:  2013-10-22       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.